onglyza comprimé
astrazeneca canada inc - saxagliptine (chlorhydrate de saxagliptine) - comprimé - 2.5mg - saxagliptine (chlorhydrate de saxagliptine) 2.5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
fasenra solution
astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists
glycopyrronium / formoterol fumarate dihydrate pressurized inhalation suspension aérosol, dose mesurée
astrazeneca canada inc - fumarate de formotérol dihydraté; glycopyrronium (bromure de glycopyrronium) - aérosol, dose mesurée - 5.8mcg; 8.3mcg - fumarate de formotérol dihydraté 5.8mcg; glycopyrronium (bromure de glycopyrronium) 8.3mcg - antimuscarinics antispasmodics
calquence capsule
astrazeneca canada inc - acalabrutinib - capsule - 100mg - acalabrutinib 100mg - antineoplastic agents
fasenra pen solution
astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists
atacand comprimé
astrazeneca canada inc - candésartan cilexétil - comprimé - 4mg - candésartan cilexétil 4mg - angiotensin ii receptor antagonists
atacand tab 8mg comprimé
astrazeneca canada inc - candésartan cilexétil - comprimé - 8mg - candésartan cilexétil 8mg - angiotensin ii receptor antagonists
atacand tab 16 mg comprimé
astrazeneca canada inc - candésartan cilexétil - comprimé - 16mg - candésartan cilexétil 16mg - angiotensin ii receptor antagonists
tenoretic 100/25mg tab comprimé
astrazeneca canada inc - aténolol; chlorthalidone - comprimé - 100mg; 25mg - aténolol 100mg; chlorthalidone 25mg - beta-adrenergic blocking agents
tenoretic 50/25mg tab comprimé
astrazeneca canada inc - aténolol; chlorthalidone - comprimé - 50mg; 25mg - aténolol 50mg; chlorthalidone 25mg - beta-adrenergic blocking agents